Advisor Group, Inc. - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 98 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$0
-100.0%
9
-99.3%
0.00%
Q3 2019$13,000
-31.6%
1,2090.0%0.00%
Q2 2019$19,000
+18.8%
1,2090.0%0.00%
Q1 2019$16,000
+700.0%
1,209
+478.5%
0.00%
Q4 2018$2,000
-33.3%
2090.0%0.00%
Q3 2018$3,000209
+10350.0%
0.00%
Q4 2016$020.0%0.00%
Q3 2016$020.0%0.00%
Q2 2016$020.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 453,000$4,168,0001.58%
Eventide Asset Management 1,086,400$9,995,0000.62%
SPHERA FUNDS MANAGEMENT LTD. 300,000$2,760,0000.47%
Lyon Street Capital, LLC 125,595$1,155,0000.46%
CARL DOMINO INC 26,000$239,0000.28%
PURA VIDA INVESTMENTS, LLC 60,000$552,0000.22%
KNOTT DAVID M 41,692$384,0000.16%
SABBY MANAGEMENT, LLC 187,500$1,725,0000.11%
FARALLON CAPITAL MANAGEMENT LLC 1,157,500$10,649,0000.11%
Telemetry Investments, L.L.C. 25,000$230,0000.11%
View complete list of STEMLINE THERAPEUTICS INC shareholders